Navigation Links
Two Blades Foundation licenses genome engineering technology to KWS
Date:7/9/2012

EVANSTON, Ill., July 9, 2012 /PRNewswire-iReach/ -- Two Blades Foundation (2Blades) has completed a non-exclusive license agreement with KWS SAAT AG (KWS) for access to 2Blades' Transcription Activator Like (TAL) effector code technology for genome engineering in certain crops. 

The TAL code technology is a new method for making highly specific changes in genomes based on novel sequence-specific DNA-binding proteins. TAL effector proteins can be designed quickly and easily to recognize virtually any DNA sequence of interest, enabling the targeting of specific locations in a genome for precise gene replacement and modulation of gene function.  2Blades holds exclusive rights for commercial uses of the technology in plants.  Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in a wide range of plant and non-plant systems.  The use of the TAL code technology in plants will enhance the efficiency and precision of the crop improvement process.

"We're pleased to complete a license with KWS for access to the TAL code technology.  It enables tools that will support their mission of delivering better seed," said 2Blades Chief Operating Officer Diana Horvath.  "KWS joins a growing list of licensees who will implement the technology in their development programs and confer a grant-back of rights to improvements that will aid 2Blades' mission of delivering benefits for subsistence farming in developing countries."  The financial terms of the agreement were not disclosed.

The TAL Code technology was discovered by Ulla Bonas, Jens Boch, Thomas Lahaye, and Sebastian Schornack at Martin-Luther University in Halle, Germany, and was named 2011 Method of the Year by the journal Nature Methods (9:1 doi:10.1038/nmeth.1852). 

The Two Blades Foundation (www.2blades.org) is a 501(c)3 not-for-profit corporation dedicated to developing durable disease resistance in agricultural crops.

Media Contact: Diana Horvath Two Blades Foundation, 847 425 1277, dmh@2blades.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Two Blades Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. A Genetic Approach For Crohns And Colitis Disease Is Financed By The Jeffrey Epstein VI Foundation
2. July is not just about BBQ's; the Arthritis National Research Foundation honors Juvenile Arthritis Awareness Month
3. BIRD - Israel-US Binational Industrial R&D Foundation to Invest $7.15 Million in Eight New Projects
4. Physicians Answer Questions About Food Biotechnology in IFIC Foundation Videos
5. Foundation Venture Capital Group Makes Eighth Start-Up Investment
6. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
7. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
8. Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland
9. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
10. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
11. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... , March 22, 2017 Oramed ... ( www.oramed.com ), a ... oral drug delivery systems, announced today that Dr. ... will deliver a presentation titled, "Oral Insulin for ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017   ... of next-generation cancer therapeutics designed to target cancer stemness ... Patricia S. Andrews as Chief Executive Officer, ... will succeed Chiang J. Li , M.D., FACP, ... company ten years ago. Under his leadership, Boston Biomedical ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare announces ... spirometer and Wellness Management System (WMS), a remote, real-time ... in 2010, PMD Healthcare is a Medical Device, Digital ... mission dedicated to creating innovative solutions that empower people ... that intent focus, PMD developed the first ever personal ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
Breaking Biology News(10 mins):